Ketoprofen, (RS) 2 (3 benzoylphenyl) propionic acid (chemical formula C16H14O3) is one of the propionic acid class of nonsteroidal anti inflammatory drugs (NSAID) with analgesic and antipyretic effects. It acts by inhibiting the body's production of prostaglandin. The report covers forecast and analysis for the ketoprofen market on a global and regional level. The study provides historic data of 2012 2016 along with a forecast from 2017 to 2022 based on both output/volume and revenue. The study then describes the drivers and restraints for the ketoprofen market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the ketoprofen market on a global level. The report has been prepared based on the synthesis, analysis, and interpretation of information about the global ketoprofen market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in global ketoprofen market. Key Regions • North America • Europe • Asia Pacific • China Key Vendors • BEC Chemicals • Cosma S.p.A. • Hamari Chemicals • Hubei Xunda Pharmaceutical • PKU Healthcare • Sanofi • request free sample to get a complete list of companies Key Questions Answered in this Report • What will the market size be in 2022? • What are the key factors driving the global ketoprofen market? • What are the challenges to market growth? • Who are the key players in the ketoprofen market? • What are the market opportunities and threats faced by the key players?